Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Harshaw Chemical Company

(Site Profile/Docket Number 087)

Location: Cleveland, Ohio

Also Known As: Harshaw Filtrol Partners, Uranium Refinery

Special Exposure Cohort Petition Information

The Special Exposure Cohort (SEC) is a unique category of employees established by The Act (42 CFR Part 83). Claims compensated under the SEC do not have to go through the dose reconstruction process. To qualify for compensation under the SEC, a covered employee must meet specific requirements (e.g., must have at least one of 22 "specified cancers," and have worked for a specified time period at one of the SEC sites). Classes of employees and work sites can be considered for addition to the SEC through a NIOSH petition process. More information about the Special Exposure Cohort can be found on our Frequently Asked Questions page.

Open/Active SEC Petitions

To date, there are no open/active SEC petitions from Harshaw Chemical Company.

Class(es) Added to the SEC

  • Atomic Weapons employees who were monitored or should have been monitored while working at the Harshaw Harvard-Denison Plant located at 1000 Harvard Avenue in Cleveland, Ohio, from August 14, 1942, through November 30, 1949, and who were employed for a number of work days aggregating at least 250 work days or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort.

    Note: This class was established from Petition 66

Petitions Qualified for Evaluation

Below is a list of the petitions that qualified for evaluation. Select a petition on the list to view the table for that particular petition.

Petitions

Petition 66Aug 14, 1942 to Nov 30, 1949

Petition 66
Steps in Petition Process: Petition Details:
Date Received

July 24, 2006

Date Qualified for Evaluation

July 25, 2006

Summary of Information in Petition

Location: Cleveland, Ohio

Job Titles and/or Job Duties: All workers at Harshaw Chemical Company plant and the laboratories of the separate facility located at 1945 East 97th Street

Period of Employment: January 1, 1942 through November 30, 1949

Copy of the Petition Received

July 24, 2006 [757 KB (2 pages)]

Federal Register Notice Announcing that a Harshaw Chemical Company SEC Petition has met the Minimum Qualifications for Review and Evaluation

August 4, 2006 [42 KB (1 page)]

SEC Petition Evaluation Report

January 2, 2007 [148 KB (24 pages)]

Evaluation Report Sent to the Advisory Board

December 5, 2006

Petition Discussed by the Advisory Board

The petition was discussed by the Advisory Board during its December 11-13, 2006, meeting in Naperville, Illinois.

Advisory Board Recommendation on SEC Petition

January 2, 2007 [396 KB (2 pages)]

HHS Letters to Congress Regarding the SEC Petition

February 1, 2007 [265 KB (6 pages)]

HHS Designation of Additional Members to the SEC

February 1, 2007 [177 KB (4 pages)]

Federal Register Notice: Designation/Determination Regarding a Class of Employees for Addition to the Special Exposure Cohort

March 1, 2007 [46 KB (1 page)]

Note: A "designation" will be published if there is a recommendation to add a class to the SEC. A "determination" will be published if there is a recommendation not to add a class to the SEC.

Effective Date for the SEC Class

March 3, 2007

Federal Register Notice: Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort

March 16, 2007 [96 KB (2 pages)]

Letter to DOL Regarding the Addition of a New Class of Employees to the SEC

March 8, 2007 [20 KB (2 pages)]

Technical Documents

If the energy employee's personal radiation information is incomplete, NIOSH will use other sources to estimate the radiation dose. This may involve using technical documents called Site Profiles, Technical Basis Documents, and Technical Information Bulletins.

Site Profile

  • An Exposure Matrix for the Harshaw Chemical Company, Cleveland, Ohio[1.4 MB (111 pages)]
    Revised June 2, 2009

    Revision Includes: Tables 5-6 and A-7 were modified and Figures A-3, A-4, A-5, A-8, A-9, and A-10 were replaced to correct an error in Rev 00. Figures A-1, A-2, A-6, and A-7 replaced to match the formatting of the modified figures. The footnote to Table B-25 was modified to clarify that the intakes listed are in terms of total alpha. The text in Section 5.9.5 was also modified to reflect this clarification. No comments were received as a result of formal internal review. Incorporates formal NIOSH review comments.

Program Evaluation Plans (PEPs) and Program Evaluation Reports (PERs)

NIOSH is committed to applying the best available science in dose reconstructions. In keeping with this commitment, completed cases with probabilities of causation less than 50% are reviewed as relevant new information becomes available. The results of these reviews are described in a Program Evaluation Report (PER). The PER details the effect, if any, of the new information on the completed dose reconstruction. If it appears that the new information may result in an increase in dose for a completed dose reconstruction with a probability of causation of less than 50%, NIOSH is committed to working with the Department of Labor to reopen and rework the dose reconstruction, as appropriate. A Program Evaluation Plan (PEP) describes plans for evaluating specific program details or issues.

  • DCAS-PER-034 Rev-0: Harshaw Chemical Company TBD Revision [15 KB (2 pages)]

    December 9, 2011

    About this Document: Determines affect of revising the Harshaw TBD on previously completed claims.

    Approved: December 9, 2011

    Summary: Several editorial changes and clarifications were included in the revision however these changes do not affect the estimated dose. Some changes may have decreased the dose but the only significant increase in the dose estimate is caused by an increase in the estimated intake rate for type S uranium from 12/1/1949 to 12/31/1953. The values are listed in Table 5-6 of both revisions.

Public Comments on Harshaw Chemical Company Documents

How to Submit Comments

Comments on Harshaw Chemical Company Documents can be submitted to the NIOSH Docket Officer electronically by email at nioshdocket@cdc.gov or printed comments can be mailed to:

NIOSH Docket Office
Robert A. Taft Laboratories, MS-C34
1090 Tusculum Avenue
Cincinnati, OH 45226

Please include the Site Profile/Docket Number (087) on all comments.

Comments Received

At this time, no comments have been submitted.

Document Archive for Harshaw Chemical Company

 
Contact DCAS:
Contact Us:
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO